Literature DB >> 10355982

Angiogenic revascularisation in ischaemic disease. Molecular techniques hold promise, though they are still some way off.

N P Brindle, M J McCarthy, P R Bell.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10355982      PMCID： PMC1115881          DOI： 10.1136/bmj.318.7197.1500

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

Review 1.  Therapeutic angiogenesis.

Authors:  T D Henry
Journal:  BMJ       Date:  1999-06-05

2.  Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation.

Authors:  T N Sato; Y Tozawa; U Deutsch; K Wolburg-Buchholz; Y Fujiwara; M Gendron-Maguire; T Gridley; H Wolburg; W Risau; Y Qin
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

Review 3.  Molecular mechanisms of coronary collateral vessel growth.

Authors:  W Schaper; W D Ito
Journal:  Circ Res       Date:  1996-11       Impact factor: 17.367

Review 4.  Vascular development: cellular and molecular regulation.

Authors:  L Beck; P A D'Amore
Journal:  FASEB J       Date:  1997-04       Impact factor: 5.191

Review 5.  Mechanisms of angiogenesis.

Authors:  W Risau
Journal:  Nature       Date:  1997-04-17       Impact factor: 49.962

Review 6.  Angiogenesis in embryos and ischemic diseases.

Authors:  G Breier; A Damert; K H Plate; W Risau
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

7.  Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization.

Authors:  T Asahara; D Chen; T Takahashi; K Fujikawa; M Kearney; M Magner; G D Yancopoulos; J M Isner
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

8.  Age-dependent impairment of angiogenesis.

Authors:  A Rivard; J E Fabre; M Silver; D Chen; T Murohara; M Kearney; M Magner; T Asahara; J M Isner
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808
  9 in total
  2 in total

1.  Effects of serum reduction and VEGF supplementation on angiogenic potential of human adipose stromal cells in vitro.

Authors:  K H Chua; F Raduan; W K Z Wan Safwani; N F M Manzor; B Pingguan-Murphy; S Sathapan
Journal:  Cell Prolif       Date:  2013-05-15       Impact factor: 6.831

Review 2.  Therapeutic angiogenesis in cardiovascular disease.

Authors:  Hilal Al Sabti
Journal:  J Cardiothorac Surg       Date:  2007-11-16       Impact factor: 1.637
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.